Fellowship · Seattle, WA
Sponsored by University of Washington School of Medicine
Genomic and phenotypic heterogeneity in prostate cancer.
Nature reviews. Urology · 2021 · 430 citations · Michael Haffner, Lawrence True
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021 · 217 citations · Maria Tretiakova, Lawrence True
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
Archives of pathology & laboratory medicine · 2021 · 227 citations · Maria Tretiakova, Lawrence True
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial.
Lancet (London, England) · 2021 · 241 citations · Maria Tretiakova
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021 · 186 citations ·
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling.
Nature communications · 2021 · 216 citations · Lawrence True
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Nature communications · 2023 · 130 citations · Lawrence True, Michael Haffner
Analysis of 3D pathology samples using weakly supervised AI.
Cell · 2024 · 86 citations · Lawrence True